Trending...
- Exelon Leader Tamla Olivier Named 2025 Technologist of the Year by Waves of Change STEM Conference - 123
- California: Governor Newsom and Acting Governor Kounalakis honor fallen Los Angeles County Sheriff's Department Detectives
- DivX Unveils Revamped Resource Guide to Help Users Easily Convert MKV to MP4
Selected patients preparing for chemotherapy will receive HuMOLYTE at no cost and provide feedback to support product development.
SACRAMENTO, Calif. - Californer -- HuMOLYTE, a medical food designed to support patients undergoing chemotherapy, today announced the launch of its Patient Experience Survey, aimed at gathering real-world feedback from individuals preparing to begin chemotherapy. This initiative offers selected participants access to HuMOLYTE at no cost in exchange for their experience and insights.
HuMOLYTE is GRAS (Generally Recognized as Safe) and formulated to help alleviate common chemotherapy-related side effects, including vomiting, diarrhea, and mouth sores, by supporting hydration, electrolyte balance, and mucosal health. In addition to ongoing formal clinical trials, the Patient Experience Survey will help the HuMOLYTE team better understand patient needs and refine product use.
"While clinical data is critical, patient voices are equally valuable in helping us improve HuMOLYTE and better serve the oncology community," said Dr. Sourabh Kharait, CEO at IGH Naturals, "This survey allows us to collect feedback from individuals actively going through chemotherapy and ensure we're addressing real-world challenges."
More on The Californer
Survey Participation Details:
About HuMOLYTE
HuMOLYTE is a medical food specifically formulated to support individuals undergoing chemotherapy by promoting hydration, electrolyte balance, and mucosal health. Backed by scientific research and developed to address common gastrointestinal side effects, HuMOLYTE is currently undergoing human clinical trials.
Apply for the Survey
Interested individuals can learn more and apply for the Patient Experience Survey at:
https://www.humolyte.com/blog/join-the-humolyte-chemotherapy-patient-experience-survey-apply-for-a-free-supply
HuMOLYTE is GRAS (Generally Recognized as Safe) and formulated to help alleviate common chemotherapy-related side effects, including vomiting, diarrhea, and mouth sores, by supporting hydration, electrolyte balance, and mucosal health. In addition to ongoing formal clinical trials, the Patient Experience Survey will help the HuMOLYTE team better understand patient needs and refine product use.
"While clinical data is critical, patient voices are equally valuable in helping us improve HuMOLYTE and better serve the oncology community," said Dr. Sourabh Kharait, CEO at IGH Naturals, "This survey allows us to collect feedback from individuals actively going through chemotherapy and ensure we're addressing real-world challenges."
More on The Californer
- Dedeaux inks global logistics firm to long-term lease for newly built warehouse in Fontana, CA
- iRobot Corporation (IRBT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- Swim Up Hill, Diversity in Aquatics, and Inglewood Host Movie Night Celebrating Aquatic Equity
- Macon's Historic Douglass Theatre Names Toni Simmons Henson as Artistic Director for Inaugural Series Celebrating the Spirit of American Theatre
- LACI Presents Reframe Systems with $25,000 Grand Prize for LA Resilient Rebuilding Cup; Prize Funding to Support Innovation Pilots Including to Reduce Cost, Time to Rebuild Resilient and Sustainable Homes in Fire-Affected Communities in Greater Los Angele
Survey Participation Details:
- Eligibility: Individuals preparing to start chemotherapy.
- What's Provided: Selected participants will receive HuMOLYTE at no cost for one chemotherapy cycle.
- Expectation: Follow the recommended protocol and complete a brief post-treatment survey.
- Purpose: Feedback will be used for product development and quality improvement.
About HuMOLYTE
HuMOLYTE is a medical food specifically formulated to support individuals undergoing chemotherapy by promoting hydration, electrolyte balance, and mucosal health. Backed by scientific research and developed to address common gastrointestinal side effects, HuMOLYTE is currently undergoing human clinical trials.
Apply for the Survey
Interested individuals can learn more and apply for the Patient Experience Survey at:
https://www.humolyte.com/blog/join-the-humolyte-chemotherapy-patient-experience-survey-apply-for-a-free-supply
Source: IGH Naturals
0 Comments
Latest on The Californer
- Parks, Recreation and Marine to Induct Two New Members into Long Beach Golf Hall of Fame
- Comedian Marc Yaffee Comes To Cloverdale August 23
- DivX Unveils Revamped Resource Guide to Help Users Easily Convert MKV to MP4
- Max Life Agency taking part in PHP Takeoff event in Las Vegas Featuring Coach K and Ray Lewis
- Quinceañera Expo Returns to San Pedro – August 24, 2025 at the DoubleTree by Hilton!
- Airbnb to Announce Second Quarter 2025 Results
- California: Governor Newsom announces local progress in reducing homelessness
- California predeploys resources in Nevada, Plumas, and Sierra counties ahead of critical fire weather conditions
- Swim Mobile and LAUSD Launch California's Largest School-Based Swim Equity Project
- AI Transforming the POD Industry: Innovations and Opportunities
- Frequent Coffee Launches as San Diego's First Decaf-Focused Specialty Coffee Company
- Visit Local Farms During 7th Annual Santa Barbara County Farm Day
- Long Beach Health Department Announces Changes to STI/HIV Services
- Chasing Elizabeth Taylor: House of Hustle Hits #1 on Amazon's Hot New Releases Chart
- Why Trump's Immigrant Onslaught is His Sure-Fire Political Meal Ticket
- From Barrio to Transgender Pioneer: Identity and the Desire to Start Anew
- Shiba Delivery Launches Same-Day Furniture Delivery and Moving Help in Los Angeles
- Sexual Harassment Law Firm CA Offers Free Consultations to Empower Harassment Victims in California
- Yours Humanly Tee Off for Education Golf Tournament, August 25, Rossmoor Golf Course
- The Reckless Return With New Single 'Darling Please'